Antares Therapeutics | Biotech/Pharma | Standout | Standout

Antares Therapeutics

Biotech/Pharma

Series A · $177.0M

Open positions (2)

Director, Financial Planning & Analysis (Biotech Experience Necessary)

Boston, MA

Sr. Scientist/Principal Scientist, Toxicology (Small Molecule)

Boston, MA

Company details

IndustryBiotech/Pharma

Funding

Total raised

$177.0M

Last stage

Series A

Investors

Omega Funds

Atlas Venture

Lightspeed Venture Partners

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

BVF Partners

Cormorant Asset Management

Founders

Adam Friedman

M.D., Ph.D. Former CEO of Scorpion Therapeutics. Previously Founder, President and CEO of Vivid Biosciences. Attended Harvard Medical School.

Keith Flaherty

M.D. Director of Clinical Research at Massachusetts General Hospital Cancer Center and Professor at Harvard Medical School. Co-founded Loxo Oncology and several other oncology companies.

Liron Bar-Peled

Named as a co-founder of Scorpion Therapeutics, the predecessor entity to Antares Therapeutics.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.